Prostacyclin administration errors in pulmonary arterial hypertension patients admitted to hospitals in the United States: A national survey

Journal of Heart and Lung Transplantation

Volumn 29, Issue 8, 2010, Pages 841-846

  Kingman, Martha S ^a   Tankersley, Mark A ^b   Lombardi, Sandra ^c   Spence, Susan ^d   Torres, Fernando ^a   Chin, Kelly S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Accredo Health Group Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

epoprostenol; prostacyclin; pulmonary arterial hypertension; pulmonary hypertension; treprostinil

Indexed keywords

PROSTACYCLIN; UNIPROST;

DRUG INFUSION; HEALTH SURVEY; HOSPITAL POLICY; HUMAN; INFUSION PUMP; INTERVIEW; MEDICATION ERROR; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; UNITED STATES;

EID: 77955716352     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.03.008     Document Type: Article

References (7)

1. D.B. Badesch, S.H. Abman, and G. Simmonneau Medical therapy for pulmonary arterial hypertension Chest 131 2007 1917 1928
2. L.J. Rubin, J. Mendoza, and M. Hood Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol) Results of a randomized trial Ann Intern Med 112 1990 485 491
3. L.L. Cuiper, P.V. Price, and B.W. Christman Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2 J Appl Physiol 80 1996 191 197
4. R. Finley http://SurveyMonkey.com (accessed November 20, 2008).
5. Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) Drug name mix-ups FDA Patient Safety News 2005
6. Institute of Medicine's (IOM) executive summary of to err is human 2000
7. A. Roncesvalles, F.W. Lee, and J. Camamo Patient safety challenges in treprostinil therapy MedSurg Nursing 17 2008 101 106